| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/24/2005 | US20050063959 By transfection with an an osteo-/chondro-inducible transcription factor gene such as Cbfa1, Dlx-5, Bapx1, Msx2, Scleraxis, or Sox9, and allowing the cells to differentiate and proliferate on a scaffold; implants |
| 03/24/2005 | US20050063958 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme |
| 03/24/2005 | US20050063946 Human pluripotent hematopoietic colony stimulating factor, method of production and use |
| 03/24/2005 | US20050063944 Method of inducing maturation of dendritic cells and uses therefor |
| 03/24/2005 | CA2578375A1 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | CA2538895A1 Factor ixa specific antibodies displaying factor viiia like activity |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538763A1 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | CA2538440A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | CA2537482A1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 03/24/2005 | CA2537217A1 Therapeutic binding molecules |
| 03/24/2005 | CA2536655A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/24/2005 | CA2533926A1 Methods and compositions for producing antigenic responses |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516931A2 DSRNA-mediated regulation of gene expression in plants |
| 03/23/2005 | EP1516926A1 Process for producing nerve cells |
| 03/23/2005 | EP1516925A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/23/2005 | EP1516924A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/23/2005 | EP1516923A2 Method of culturing cells |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 03/23/2005 | EP1516662A1 Preparation comprising at least two nanoemulsions |
| 03/23/2005 | EP1516629A2 Humanized anti CD-11a antibodies |
| 03/23/2005 | EP1516274A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516057A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 03/23/2005 | EP1516056A2 Thioesterase-related nucleic acid sequences and methods of use for the production of plants with modified fatty acid composition |
| 03/23/2005 | EP1516055A2 Fiber shaft modifications for efficient targeting |
| 03/23/2005 | EP1516052A1 Immunomodulation using altered dendritic cells |
| 03/23/2005 | EP1516050A2 Generation of plants with improved pathogen resistance |
| 03/23/2005 | EP1516046A2 Genes encoding baeyer-villiger monooxygenases |
| 03/23/2005 | EP1516045A2 Glutamine-free medium |
| 03/23/2005 | EP1516044A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 03/23/2005 | EP1516014A1 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof |
| 03/23/2005 | EP1515990A2 Antagonists of cxcr3-binding cxc chemokines |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 03/23/2005 | EP1515752A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515601A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/23/2005 | EP1438396A4 Gene transfer composition and method |
| 03/23/2005 | EP1421182A4 Methods of inducing differentiation of stem cells |
| 03/23/2005 | EP1330176A4 METHOD FOR i IN VIVO /i , i EX VIVO /i AND i IN VITRO /i REPAIR AND REGENERATION OF CARTILAGE AND COLLAGEN AND BONE REMODELING |
| 03/23/2005 | EP1297119B9 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 03/23/2005 | EP1114166B1 Method for down-regulating osteoprotegerin ligand activity |
| 03/23/2005 | EP1012241B1 Screening assays for g protein coupled receptor agonists and antagonists |
| 03/23/2005 | EP0981636B1 Lentivirus-based gene transfer vectors |
| 03/23/2005 | EP0845005B1 Traf inhibitors |
| 03/23/2005 | EP0779928B1 Use of an acetohydroacid synthase promoter for expression of introduced genes in plants |
| 03/23/2005 | EP0703983B1 Regulation of plant growth |
| 03/23/2005 | EP0672146B1 Biocidal chitin binding proteins |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599797A Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |
| 03/23/2005 | CN1599794A Production of viruses, viral isolates and vaccines |
| 03/23/2005 | CN1599793A Chondrocyte precursors derived from human embryonic stem cells |
| 03/23/2005 | CN1599792A Nutrient medium for maintaining neural cells in injured nervous system |
| 03/23/2005 | CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599749A Peptides promoting cell adherence, growth and secretion |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/23/2005 | CN1597988A Human sel-10 polypeptides and polynucleotides that encode them |
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597950A Icam-4 materials and methods |
| 03/23/2005 | CN1597937A Extracting material of placental villi cell and its application for inducing differentiating of matrax stem cell |
| 03/23/2005 | CN1597936A Process for cultivating and generating stem cell from fatty organization |
| 03/23/2005 | CN1597935A Process for extracting stem cell of umbilical cord living cell placental cyonin |
| 03/23/2005 | CN1597934A Simple process for cultivating organization cell of antler |
| 03/23/2005 | CN1597933A Process for construvting transgene teceptor system of rye grass and its application |
| 03/23/2005 | CN1597932A Process for breaking cell or breaking wall and its mechanical apparatus |
| 03/23/2005 | CN1597899A Bleaching compositions containing multiply-substituted protease variants |
| 03/23/2005 | CN1597898A Cleaning compositions containing multiply-substituted protease variantsus |
| 03/23/2005 | CN1596615A Method of proceeding hybridization using animal sperm and pistil of melon fruit plant |
| 03/23/2005 | CN1194090C Growth factor and genetic sequence for encoding same |
| 03/23/2005 | CN1194086C Preparing method method of neural stem cell preparation, |
| 03/22/2005 | US6870076 Homeobox genes encoding proteins participating in differentiation |
| 03/22/2005 | US6870038 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W |
| 03/22/2005 | US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6869926 Comprises amylin/adrenomedullin which stimulates chondrocyte proliferation; for treatment of cartilage disorders/bone growth disorders |
| 03/22/2005 | US6869794 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1 |
| 03/22/2005 | US6869772 Method for labeling individual cells |
| 03/22/2005 | US6869766 Gene associated with regulation of adiposity and insulin response |
| 03/22/2005 | CA2127541C Recombinant swinepox virus |
| 03/17/2005 | WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | WO2005024030A1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences |
| 03/17/2005 | WO2005024028A1 Utilization of zpt2-3 zinc finger type transcriptional factor in constructing plant with enhanced resistance to dryness |
| 03/17/2005 | WO2005024015A1 Expression vector |
| 03/17/2005 | WO2005024004A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell |
| 03/17/2005 | WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 03/17/2005 | WO2005023994A2 Modified oligonucleotides for telomerase inhibition |
| 03/17/2005 | WO2005023990A2 Trans-splicing mediated photodynamic therapy |
| 03/17/2005 | WO2005023988A2 Modulation of cell intrinsic strain to control matrix synthesis, secretion, organization and remodeling |
| 03/17/2005 | WO2005023980A2 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 03/17/2005 | WO2005023865A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 03/17/2005 | WO2005023324A1 Meniscal superfacial zone cells for articular cartilage repair |
| 03/17/2005 | WO2005002643A3 Method and products for delivering biological molecules to cells using multicomponent nanostructures |
| 03/17/2005 | WO2004101801A3 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding generic tools, as well as the applications of these non-pathogenic amplicons vectors |